PL2381784T3 - Interwencyjny produkt odżywczy w celu poprawy funkcji i siły mięśni - Google Patents

Interwencyjny produkt odżywczy w celu poprawy funkcji i siły mięśni

Info

Publication number
PL2381784T3
PL2381784T3 PL09832494T PL09832494T PL2381784T3 PL 2381784 T3 PL2381784 T3 PL 2381784T3 PL 09832494 T PL09832494 T PL 09832494T PL 09832494 T PL09832494 T PL 09832494T PL 2381784 T3 PL2381784 T3 PL 2381784T3
Authority
PL
Poland
Prior art keywords
strength
nutritional intervention
muscular function
improving muscular
improving
Prior art date
Application number
PL09832494T
Other languages
English (en)
Inventor
John Rathmacher
John Fuller
Shawn Baier
Steven Nissen
Naji Abumrad
Original Assignee
Metabolic Technologies, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Metabolic Technologies, Inc. filed Critical Metabolic Technologies, Inc.
Publication of PL2381784T3 publication Critical patent/PL2381784T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A23L33/155—Vitamins A or D
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/06—Anabolic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL09832494T 2008-12-09 2009-12-09 Interwencyjny produkt odżywczy w celu poprawy funkcji i siły mięśni PL2381784T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12106508P 2008-12-09 2008-12-09
EP09832494.0A EP2381784B1 (en) 2008-12-09 2009-12-09 Nutritional intervention for improving muscular function and strength
PCT/US2009/067382 WO2010068696A1 (en) 2008-12-09 2009-12-09 Nutritional intervention for improving muscular function and strength

Publications (1)

Publication Number Publication Date
PL2381784T3 true PL2381784T3 (pl) 2019-01-31

Family

ID=42243059

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09832494T PL2381784T3 (pl) 2008-12-09 2009-12-09 Interwencyjny produkt odżywczy w celu poprawy funkcji i siły mięśni

Country Status (9)

Country Link
US (1) US8815280B2 (pl)
EP (2) EP2381784B1 (pl)
CA (1) CA2746420C (pl)
DK (1) DK2381784T3 (pl)
ES (1) ES2689700T3 (pl)
HU (1) HUE039841T2 (pl)
PL (1) PL2381784T3 (pl)
PT (1) PT2381784T (pl)
WO (1) WO2010068696A1 (pl)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050215640A1 (en) 2004-03-26 2005-09-29 Baxter Jeffrey H HMB compositions and uses thereof
CA2632262C (en) 2005-12-19 2015-04-07 Abbott Laboratories Method of using .beta.-hydroxy-.beta.-methylbutyrate
US9707241B2 (en) * 2008-12-09 2017-07-18 Metabolic Technologies, Inc. Nutritional intervention for improving muscular function and strength
US11173167B2 (en) * 2008-12-09 2021-11-16 Metabolic Technologies, Inc. Nutritional intervention for improving muscular function and strength
US9259430B2 (en) * 2008-12-09 2016-02-16 Metabolic Technologies, Inc. Nutritional intervention for improving muscular function and strength
US9770424B2 (en) * 2008-12-09 2017-09-26 Metabolic Technologies, Inc. Nutritional intervention for improving muscular function and strength
US9539224B2 (en) * 2008-12-09 2017-01-10 Metabolic Technologies, Inc. Nutritional intervention for improving muscular function and strength
PT2512236T (pt) * 2009-12-18 2016-12-29 Metabolic Tech Inc Método aperfeiçoado de administração de beta-hidroxi-beta-metilbutirato (hmb)
EP2461704B1 (en) 2010-01-29 2013-10-09 Abbott Laboratories Aseptically packaged nutritional liquids comprising hmb
BR112012017690A2 (pt) 2010-01-29 2015-09-01 Abbott Lab Emulsões nutricionais compreendendo hmb de cálcio
US9693577B2 (en) 2010-01-29 2017-07-04 Abbott Laboratories Method of preparing a nutritional powder comprising spray dried HMB
TWI526161B (zh) * 2010-06-10 2016-03-21 亞培公司 包含鈣ｈｍｂ及可溶性蛋白質之實質上透明營養液
US20130338228A1 (en) * 2010-12-27 2013-12-19 Abbott Laboratories Methods for facilitating muscle recovery after a period of disuse using beta-hydroxy-beta-methylbutyrate
WO2012097061A1 (en) * 2011-01-13 2012-07-19 Abbott Laboratories Nutritional compositions and methods for improving skeletal muscle protein metabolism
US9326956B2 (en) 2011-02-17 2016-05-03 Abbott Laboratories Methods for improving brain development and cognitive function using beta-hydroxy-beta methylbutyrate
WO2013067485A1 (en) 2011-11-03 2013-05-10 University Of Florida Research Foundation, Inc. Nutritional supplement for weight management
US20140156297A1 (en) * 2012-08-03 2014-06-05 Axelacare Holdings, Inc. Computer program, method, and system for pharmacist-assisted treatment of patients
US20140039907A1 (en) * 2012-08-03 2014-02-06 AxelaCare Health Solutions, Inc. Computer program, method, and system for collecting patient data with a portable electronic device
AU2013312113B2 (en) * 2012-09-10 2018-08-02 Metabolic Technologies, LLC Composition of HMB and ATP and methods of use
US20150238447A1 (en) * 2012-09-17 2015-08-27 Abbott Laboratories Beta-hydroxy-beta-methylbutryic acid-containing compositions and uses thereof
BR112015007131A2 (pt) * 2012-10-04 2017-07-04 Abbott Lab métodos para melhorar o efeito de egcg em atenuar a perda muscular esquelética
AU2014386220B2 (en) 2013-03-14 2018-04-26 Metabolic Technologies, Inc. Liquids and foodstuffs containing beta-hydroxy-beta-methylbutyrate (HMB) in free acid form
CN106061291A (zh) * 2013-12-18 2016-10-26 雅培公司 使用绿茶提取物来增加骨骼肌蛋白质合成的方法
WO2015148982A1 (en) 2014-03-27 2015-10-01 Winterfield Roland W Beta-hydroxy beta-methylbutyrate for alleviating statin myopathy
US20160184248A1 (en) * 2014-12-15 2016-06-30 University Of Central Florida Research Foundation Inc. Compositions and methods of use of -hydroxy-methylbutyrate (hmb) resulting in an acute endocrine response
US20160346238A1 (en) * 2015-06-01 2016-12-01 Metabolic Technologies, Inc. Compositions and Methods of Use of -hydroxy--methylbutyrate (HMB) for Decreasing Fat Mass
PL3528801T3 (pl) * 2016-10-21 2025-02-03 Metabolic Technologies, LLC Kompozycje i sposoby zastosowania beta-hydroksy-beta-metylomaślanu (hmb) i probiotyków
US12370159B2 (en) 2016-10-21 2025-07-29 Metabolic Technologies, LLC Compositions and methods of use of beta-hydroxy-beta-methylbutyrate (HMB) and probiotics
US10888576B2 (en) 2018-10-08 2021-01-12 Metabolic Technologies, Inc. Composition of HMB and ATP and methods of use
EP3947336B1 (en) 2019-04-02 2023-03-15 Evonik Operations GmbH Process for preparing 3-hydroxy-3-methylbutyrate (hmb) and salts thereof
JP2021070643A (ja) * 2019-10-30 2021-05-06 小林製薬株式会社 筋肉量改善用組成物
BR112022025819A2 (pt) * 2020-06-17 2023-03-07 Metabolic Tech Llc Métodos para aumentar a massa muscular, para aumentar a força e para aprimorar a função muscular de um ser humano que não se exercita
EP3951016A1 (en) 2020-08-05 2022-02-09 Evonik Operations GmbH Method for preparing 3-hydroxy-3-methylbutyric acid (hmb) or salts thereof
CA3206564A1 (en) * 2021-01-28 2022-08-04 Jose Maria Lopez Pedrosa Methods and nutritional compositions for improving muscle energy production and/or strength
JP2024513816A (ja) * 2021-03-31 2024-03-27 アボット・ラボラトリーズ インスリン産生及び分泌を改善するための方法ならびに組成物
WO2022225786A1 (en) * 2021-04-22 2022-10-27 Abbott Laboratories Methods and compositions for improving muscle strength and/or reducing muscle loss
CN117502654A (zh) * 2023-05-09 2024-02-06 内蒙古欧世蒙牛乳制品有限责任公司 一种改善肌肉及提高行动力的组合物及食品和组合物的应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5028440A (en) 1990-01-30 1991-07-02 Iowa State University Research Foundation, Inc. Method of raising meat producing animals to increase lean tissue development
US5087472A (en) 1990-01-30 1992-02-11 Iowa State University Research Foundation, Inc. Feed compositions for domestics animals containing hydroxymethylbutyrate
US4992470A (en) 1990-02-08 1991-02-12 Iowa State University Research Foundation, Inc. Method of enhancing immune response of mammals
JPH03256371A (ja) * 1990-03-06 1991-11-15 Eastman Kodak Japan Kk 発光ダイオード及びそのアレイ
ES2142353T3 (es) 1992-09-16 2000-04-16 Univ Iowa State Res Found Inc Procedimiento para reducir los niveles de colesterol total y de colesterol asociado a lipoproteinas de baja densidad en sangre.
US5348979A (en) 1992-12-23 1994-09-20 Iowa State University Research Foundation Inc. Method of promoting nitrogen retention in humans
US6103764A (en) 1997-11-07 2000-08-15 Iowa State University Research Foundation, Inc. Method for increasing the aerobic capacity of muscle
US6031000A (en) 1998-06-23 2000-02-29 Iowa State University Research Foundation, Inc. Composition comprising β-hydroxy-β-methylbutyric acid and at least one amino acid and methods of use
US6291525B1 (en) 1999-09-08 2001-09-18 Iowa State University Research Foundation, Inc. Method for improving a human's perception of his emotional state
US7445807B2 (en) * 2002-10-15 2008-11-04 Western Holdings, Llc Agglomerated granular protein-rich nutritional supplement
US20050215640A1 (en) 2004-03-26 2005-09-29 Baxter Jeffrey H HMB compositions and uses thereof
US7887852B2 (en) * 2005-06-03 2011-02-15 Soft Gel Technologies, Inc. Soft gel capsules containing polymethoxylated flavones and palm oil tocotrienols
CA2632262C (en) * 2005-12-19 2015-04-07 Abbott Laboratories Method of using .beta.-hydroxy-.beta.-methylbutyrate
CA2660570C (en) 2006-08-24 2016-08-09 University Of Tennessee Research Foundation Substituted acylanilides and methods of use thereof

Also Published As

Publication number Publication date
CA2746420C (en) 2019-11-12
HUE039841T2 (hu) 2019-02-28
DK2381784T3 (en) 2018-10-22
PT2381784T (pt) 2018-10-30
EP2381784B1 (en) 2018-07-11
EP3403516A1 (en) 2018-11-21
EP2381784A1 (en) 2011-11-02
ES2689700T3 (es) 2018-11-15
US8815280B2 (en) 2014-08-26
CA2746420A1 (en) 2010-06-17
WO2010068696A1 (en) 2010-06-17
EP2381784A4 (en) 2013-10-16
US20100179112A1 (en) 2010-07-15

Similar Documents

Publication Publication Date Title
PL2381784T3 (pl) Interwencyjny produkt odżywczy w celu poprawy funkcji i siły mięśni
EP2277138A4 (en) PLACEMENT OF ARTICLES
IL210804A (en) Benzylidenehydrazides and their uses
HUE037323T2 (hu) Törlõkar-törlõlapát összekapcsolás, valamint törlõlapát
PL2315705T3 (pl) Zamknięcie z przyrządem
GB0808575D0 (en) Compilign and linking
ZA201104742B (en) Strains and methods for improving ruminant health and/or performance
GB2463514C (en) Imidazolidine compounds and uses therefor
GB0819720D0 (en) Methods and products
EP2291377A4 (en) IMIDAZOPYRIMIDINONE AND ITS USES
ZA201103456B (en) Leukolectins and uses thereof
GB0805279D0 (en) Food supplement
PL2247601T3 (pl) Tiazopirymidynony i ich zastosowanie
ZA201104161B (en) Dihydroetorphines and their preparation
ZA201005417B (en) Nutritious drink
ZA201108855B (en) Wellness shoe and method
GB0802327D0 (en) An improved tortilla press
GB0813359D0 (en) Halfin and/or platerfin
GB0809973D0 (en) Web-based content
AU4085P (en) AR584 Neotyphodium coenophialum
GB0810609D0 (en) Methods and uses
GB0816523D0 (en) Methods and uses
GB0808857D0 (en) Methdos and uses
IL192051A0 (en) Coffee with vitamins
GB0803731D0 (en) Methods and products